bims-ovdlit Biomed News
on Ovarian cancer: early diagnosis, liquid biopsy and therapy
Issue of 2026–03–01
five papers selected by
Lara Paracchini, Humanitas Research
  1. ESMO Clinical Practice Guideline Express Update on the management of epithelial ovarian cancer.
  2. Preventive vaccines for hereditary cancer syndromes.
  3. Cancer risks in the Lynch syndromes.
  4. Galleri cancer tests: Controversial NHS trial fails to meet key goal.
  5. Restoring Function to a Variant of p53 in Solid Tumors.
  1. ESMO Open. 2026 Feb;pii: S2059-7029(25)01902-7. [Epub ahead of print]11(2): 106032
    ESMO Clinical Practice Guideline Express Update on the management of epithelial ovarian cancer.
    ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
      
    Keywords:  epithelial ovarian cancer; first-line maintenance rucaparib; guideline; mirvetuximab soravtansine (MIRV); platinum-resistant
    DOI:  https://doi.org/10.1016/j.esmoop.2025.106032
  2. Nat Med. 2026 Feb 26.
    Preventive vaccines for hereditary cancer syndromes.
    Yonina R Murciano-Goroff, Zsofia K Stadler.
      
    DOI:  https://doi.org/10.1038/s41591-026-04248-2
  3. J Natl Cancer Inst. 2026 Feb 23. pii: djag029. [Epub ahead of print]
    Cancer risks in the Lynch syndromes.
    William D Foulkes, Aysel Ahadova.
      
    DOI:  https://doi.org/10.1093/jnci/djag029
  4. BMJ. 2026 Feb 24. 392 s364
    Galleri cancer tests: Controversial NHS trial fails to meet key goal.
    Deborah Cohen.
      
    DOI:  https://doi.org/10.1136/bmj.s364
  5. N Engl J Med. 2026 Feb 26. 394(9): 922-925
    Restoring Function to a Variant of p53 in Solid Tumors.
    Xin Lu.
      
    DOI:  https://doi.org/10.1056/NEJMe2516747
This page is being maintained by Thomas Krichel. It was last updated on 2026‒03‒06 at 2:43.